Narges Karimi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Narges Karimi has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Maryam Fekri Soufiabadi
Pathology and Stem Cell Research Center, Kerman University of Medical Sciences, Kerman, Iran
2 shared publications - Shahriar Dabiri
Pathology and Stem Cell Research Center, Kerman University of Medical Sciences, Kerman, Iran
2 shared publications - Ali Afgar
Research Center for Hydatid Disease in Iran, Kerman University of Medical Sciences, Kerman, Iran
1 shared publication - Hannaneh Bazgir
Pathology and Stem Cell Research Center, Kerman University of Medical Sciences, Kerman, Iran
1 shared publication - Mahsa Ziasistani
Pathology and Stem Cell Research Center, Kerman University of Medical Sciences, Kerman, Iran
1 shared publication - Maryam Iranpour
Pathology and Stem Cell Research Center, Kerman University of Medical Sciences, Kerman, Iran
1 shared publication
Latest Publications
- 24 July 2026
- Published by Springer Nature in Cytotechnology
- Vol. 78 (5) , 164
Anticancer potential of Viola cornuta–derived green-synthesized CuO nanoparticles via ROS-induced apoptosis in breast cancer cell lines
Breast cancer is associated with significant mortality amongst women universally. Common treatments face various difficulties, including the development of drug resistance. This fact necessitates the exploration of new therapeutic protocols. Our study evaluated the apoptotic effects of green-synthesized copper oxide nanoparticles (CuO-NPs) on breast cancer cells (MCF7) compared to normal epithelial cells (MCF10) through a series of in vitro assays. Copper oxide nanoparticles were obtained from Viola corneta leaves. The crystalline structure and spherical morphology of the nanoparticles were represented by X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), and scanning electron microscopy (SEM). Cells were treated with multiple concentrations of CuO-NPs. Cell viability assay revealed dose-dependent IC50 values of 35.4 µg/mL and 85 µg/mL for MCF7 and MCF10A, respectively. CuO-NPs remarkably promoted ROS production and induced apoptosis, as evidenced by Annexin V/PI staining. Flow cytometric analysis exhibited a marked rise in the SubG1 phase of the cell cycle in the MCF7 population. Ultimately, real-time PCR analysis also exhibited a higher expression of pro-apoptotic than anti-apoptotic genes in treated cells. These findings emphasize the ability of CuO-NPs to induce apoptosis in breast cancer cell lines and highlight their effectiveness in selectively targeting the cancer cells rather than the normal cells.
- 24 July 2026
- Published by Springer Nature in Cytotechnology
- Vol. 78 (5) , 164
Anticancer potential of Viola cornuta–derived green-synthesized CuO nanoparticles via ROS-induced apoptosis in breast cancer cell lines
Breast cancer is associated with significant mortality amongst women universally. Common treatments face various difficulties, including the development of drug resistance. This fact necessitates the exploration of new therapeutic protocols. Our study evaluated the apoptotic effects of green-synthesized copper oxide nanoparticles (CuO-NPs) on breast cancer cells (MCF7) compared to normal epithelial cells (MCF10) through a series of in vitro assays. Copper oxide nanoparticles were obtained from Viola corneta leaves. The crystalline structure and spherical morphology of the nanoparticles were represented by X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), and scanning electron microscopy (SEM). Cells were treated with multiple concentrations of CuO-NPs. Cell viability assay revealed dose-dependent IC50 values of 35.4 µg/mL and 85 µg/mL for MCF7 and MCF10A, respectively. CuO-NPs remarkably promoted ROS production and induced apoptosis, as evidenced by Annexin V/PI staining. Flow cytometric analysis exhibited a marked rise in the SubG1 phase of the cell cycle in the MCF7 population. Ultimately, real-time PCR analysis also exhibited a higher expression of pro-apoptotic than anti-apoptotic genes in treated cells. These findings emphasize the ability of CuO-NPs to induce apoptosis in breast cancer cell lines and highlight their effectiveness in selectively targeting the cancer cells rather than the normal cells.
- 14 December 2025
- Published by Elsevier in Gene Reports
- Vol. 42
Impact of LMNA gene polymorphism (rs581342) on lung cancer susceptibility: Evidence from a southeast Iranian population
- 14 December 2025
- Published by Elsevier in Gene Reports
- Vol. 42
Impact of LMNA gene polymorphism (rs581342) on lung cancer susceptibility: Evidence from a southeast Iranian population